Drug Trial Radar · NCT03915366
Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia
Last checked: Nov 20, 2026Latest source record: Sep 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
563
Actual
Start
Mar 1, 2020
Primary completion
Jan 31, 2025
Study completion Jan 31, 2025
Sponsor
- Lead sponsor
- Hospital Universitario 12 de OctubreAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University Hospital, Bordeaux; Institut National de la Santé Et de la Recherche Médicale, France; PENTA Foundation; Centre Hospitalier Cocody; Malawi-Liverpool-Wellcome Trust Clinical Research Programme; Eduardo Mondlane University; Centro de Investigação em Saúde de Manhiça; Stichting Katholieke Universiteit; Barcelona Institute for Global Health; University of Lincoln; Makerere University; University Teaching Hospital, Lusaka, Zambia; University of Zimbabwe; Kamuzu Central Hospital; Servicio Madrileño de Salud, Madrid, Spain
- First posted
- Apr 16, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 28 days, up to 365 days
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial will evaluate whether empirical treatment against cytomegalovirus and tuberculosis improves survival of HIV-infected infants with severe pneumonia.
Conditions
- Pneumonia
- HIV/AIDS
- Tuberculosis
- Cytomegalovirus Infections
Interventions
Valganciclovir Oral Solution [Valcyte]Drug
Treatment for CMV
Tuberculostatic AgentsDrug
Treatment for tuberculosis
Primary outcomes
What the sponsor says the trial is designed to measure.
- MortalityTime frame: 1 year
Locations
13 sites in 11 countries. Site status is shown where the registry gives one.
Programme PACCI. Centre Hospitalier Cocody.
Abidjan, Côte d’Ivoire
Université de Bourdeaux
Bourdeaux, France
INSERM
Toulouse, France
PENTA Foundation
Padova, Italy
Malawi Liverpool Welcome Trust. Queen Elizabeth Central Hospital College of Medicine
Blantyre, Malawi
Cemtro de Investigaçao em Saúde da Manhiça
Manhiça, Mozambique
Hospital Central Maputo
Maputo, Mozambique
Stichting Katholieke Universiteit Radboudumc
Nijmegen, Netherlands
Fundación para la Investigación Biomédica del Hospital 12 de Octubre
Madrid, Spain
Makerere University - Mulago Hospital
Kampala, Uganda
University of Lincoln
Lincoln, United Kingdom
Lusaka Teaching Hospital
Lusaka, Zambia
University of Zimbabwe Clinical Research Centre
Harare, Zimbabwe
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.